Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy

References

• Ansar M, Serrano D, Papademetriou I, et al. (2013). Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting. ACS Nano 7:10597–611
   PubMed Web of Science ®Google Scholar
• Bhowmick T, Berk E, Cui X, et al. (2012). Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1. J Control Release 157:485–92
   PubMed Web of Science ®Google Scholar
• Bouis D, Hospers GA, Meijer C, et al. (2001). Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis 4:91–102
   PubMedGoogle Scholar
• Calderon AJ, Bhowmick T, Leferovich J, et al. (2011). Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers. J Control Release 150:37–44
   PubMed Web of Science ®Google Scholar
• Chai GH, Hu FQ, Sun J, et al. (2014). Transport pathways of solid lipid nanoparticles across Madin-Darby canine kidney epithelial cell monolayer. Mol Pharm 11:3716–26
   PubMed Web of Science ®Google Scholar
• Chen W, Pendyala S, Natarajan V, et al. (2008). Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition. Am J Physiol Lung Cell Mol Physiol 295:L575–83
   PubMed Web of Science ®Google Scholar
• Chen W, Sammani S, Mitra S, et al. (2012). Critical role for integrin-β4 in the attenuation of murine acute lung injury by simvastatin. Am J Physiol Lung Cell Mol Physiol 303:L279–85
   PubMed Web of Science ®Google Scholar
• Cornier MA, Eckel RH. (2015). Non-traditional dosing of statins in statin-intolerant patients-is it worth a try? Curr Atheroscler Rep 17:475
   PubMed Web of Science ®Google Scholar
• Craig TR, Duffy MJ, Shyamsundar M, et al. (2011). A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (the HARP study). Am J Respir Crit Care Med 183:620–6
   PubMed Web of Science ®Google Scholar
• Du YZ, Weng Q, Yuan H, et al. (2010). Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. ACS Nano 4:6894–902
   PubMed Web of Science ®Google Scholar
• Gentile F, Curcio A, Indolfi C, et al. (2008). The margination propensity of spherical particles for vascular targeting in the microcirculation. J Nanobiotechnol 6:9
   PubMedGoogle Scholar
• Gotts JE, Matthay MA. (2011). Mesenchymal stem cells and acute lung injury. Crit Care Clin 27:719–33
   PubMed Web of Science ®Google Scholar
• Howard M, Zern BJ, Anselmo AC, et al. (2014). Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano 8:4100–32
   PubMed Web of Science ®Google Scholar
• Hsu J, Northrup L, Bhowmick T, et al. (2012). Enhanced delivery of α-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders. Nanomedicine 8:731–9
   PubMed Web of Science ®Google Scholar
• Huo M, Gao R, Jiang L, et al. (2013). Suppression of LPS-induced inflammatory responses by gossypol in RAW 264.7 cells and mouse models. Int Immunopharmacol 15:442–9
   PubMed Web of Science ®Google Scholar
• Jacobson JR, Barnard JW, Grigoryev DN, et al. (2005). Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 288:L1026–32
   PubMed Web of Science ®Google Scholar
• Jacobson JR, Dudek SM, Birukov KG, et al. (2004). Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am J Respir Cell Mol Biol 30:662–70
   PubMed Web of Science ®Google Scholar
• Kilic B, Kruse M, Stahlmann R. (2006). The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926). Toxicology 218:30–8
   PubMed Web of Science ®Google Scholar
• Lanbeck P, Odenholt I, Riesbeck K. (2004). Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis. J Antimicrob Chemother 53:174–9
   PubMed Web of Science ®Google Scholar
• Lu YM, Huang JY, Wang H, et al. (2014). Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles. Biomaterials 35:530–7
   PubMed Web of Science ®Google Scholar
• Mathew B, Huang Y, Jacobson JR, et al. (2011). Simvastatin attenuates radiation-induced murine lung injury and dysregulated lung gene expression. Am J Respir Cell Mol Biol 44:415–22
   PubMed Web of Science ®Google Scholar
• Matthay MA, Zemans RL. (2011). The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 6:147–63
   PubMed Web of Science ®Google Scholar
• McClintock D, Zhuo H, Wickersham N, et al. (2008). Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care 12:R41
   PubMed Web of Science ®Google Scholar
• Muller HC, Hellwig K, Rosseau S, et al. (2010). Simvastatin attenuates ventilator-induced lung injury in mice. Crit Care 14:R143
   PubMed Web of Science ®Google Scholar
• Muro S, Garnacho C, Champion JA, et al. (2008). Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther 16:1450–8
   PubMed Web of Science ®Google Scholar
• Oh B, Lee M. (2014). Combined delivery of HMGB-1 box A peptide and S1PLyase siRNA in animal models of acute lung injury. J Control Release 175:25–35
   PubMed Web of Science ®Google Scholar
• Radjabova V, Mastroeni P, Skjodt K, et al. (2015). TARM1 is a novel leukocyte receptor complex-encoded ITAM receptor that costimulates proinflammatory cytokine secretion by macrophages and neutrophils. J Immunol 195:3149–59
   PubMed Web of Science ®Google Scholar
• Sadikot RT. (2014). The potential role of nano- and micro-technology in the management of critical illnesses. Adv Drug Deliv Rev 77:27–31
   PubMed Web of Science ®Google Scholar
• Shyamsundar M, McKeown ST, O’Kane CM, et al. (2009). Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 179:1107–14
   PubMed Web of Science ®Google Scholar
• Steiner S, Speidl WS, Pleiner J, et al. (2005). Simvastatin blunts endotoxin-induced tissue factor in vivo. Circulation 111:1841–6
   PubMed Web of Science ®Google Scholar
• Tang X, Wang G, Shi R, et al. (2015). Enhanced tolerance and antitumor efficacy by docetaxel-loaded albumin nanoparticles. Drug Deliv 23:2686–96
   PubMed Web of Science ®Google Scholar
• Yuan H, Chen CY, Chai GH, et al. (2013). Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Mol Pharm 10:1865–73
   PubMed Web of Science ®Google Scholar
• Yu Q, Hu X, Ma Y, et al. (2016). Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus. Drug Deliv 23:1469–75
   PubMed Web of Science ®Google Scholar
• Zhai Y, Zhai G. (2014). Advances in lipid-based colloid systems as drug carrier for topic delivery. J Control Release 193:90–9
   PubMed Web of Science ®Google Scholar